Literature DB >> 1788120

An approach to the diagnosis and treatment of membranous laryngotracheobronchitis in infants and children.

P G Gallagher1, C M Myer.   

Abstract

The purpose of this study is to report 18 cases of membranous laryngotracheobronchitis (MLTB) and to review 143 published cases in order to accurately characterize the epidemiology, presentation, clinical course, treatment, and outcome of patients with this disorder. The male:female ratio was 2:1; mean age was four years. Most patients presented with acute onset of respiratory distress with fever, toxicity, and stridor after a prodrome of upper respiratory tract infection lasting a few days. White blood cell counts varied over a wide range, and blood culture results were rarely positive. Respiratory cultures commonly yielded Staphylococcus aureus or Haemophilus influenzae. Diagnosis was usually confirmed by airway radiographs or endoscopy. An artificial airway was required in 83% of patients. Complications included respiratory failure, toxic shock syndrome, anoxic encephalopathy, and death. MLTB is a serious, potentially fatal cause of acute infectious airway obstruction in infants and children that requires an organized approach to diagnosis and management.

Entities:  

Mesh:

Year:  1991        PMID: 1788120     DOI: 10.1097/00006565-199112000-00004

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

1.  Systemic complications associated with bacterial tracheitis.

Authors:  J Britto; P Habibi; S Walters; M Levin; S Nadel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

2.  Bacterial tracheitis in children: Approach to diagnosis and treatment.

Authors:  Bandar Al-Mutairi; Valerie Kirk
Journal:  Paediatr Child Health       Date:  2004-01       Impact factor: 2.253

Review 3.  Upper Airway Obstruction in Children.

Authors:  Anirban Mandal; Sushil K Kabra; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2015-06-25       Impact factor: 5.319

Review 4.  Infraglottic and bronchial infections.

Authors:  A Uba
Journal:  Prim Care       Date:  1996-12       Impact factor: 2.907

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.